Article Versions Notes

Sahrayi H, Hosseini E, Karimifard S, Khayam N, Meybodi SM, Amiri S, Bourbour M, Farasati Far B, Akbarzadeh I, Bhia M, et al. Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression. Pharmaceuticals. 2022; 15(1):6. https://doi.org/10.3390/ph15010006

Sahrayi, Hamidreza, Elham Hosseini, Sara Karimifard, Nazanin Khayam, Seyed Mohammadmahdi Meybodi, Sahar Amiri, Mahsa Bourbour, Bahareh Farasati Far, Iman Akbarzadeh, Mohammed Bhia, and et al. 2022. "Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression" Pharmaceuticals 15, no. 1: 6. https://doi.org/10.3390/ph15010006

Sahrayi, H., Hosseini, E., Karimifard, S., Khayam, N., Meybodi, S. M., Amiri, S., Bourbour, M., Farasati Far, B., Akbarzadeh, I., Bhia, M., Hoskins, C., & Chaiyasut, C. (2022). Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression. Pharmaceuticals, 15(1), 6. https://doi.org/10.3390/ph15010006